Acadia Pharmaceuticals | Activos Circulantes



Current Assets Cambio Fecha
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
ALKERMES USD 1.42B 167.74M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Cytokinetics USD 1.11B 89.34M 2024-12
Eisai JPY 761.1B 79.19B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Incyte USD 3.23B 7.24M 2025-03
J&J USD 71.55B 15.66B 2025-03
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Prothena USD 485.41M 49.57M 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Acadia Pharmaceuticals Activos Circulantes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.